Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Evidence that the rabbit proton-peptide co-transporter PepT1 is a multimer when expressed in Xenopus laevis oocytes.
Panitsas KE
,
Boyd CA
,
Meredith D
.
???displayArticle.abstract???
To test whether the rabbit proton-coupled peptide transporter PepT1 is a multimer, we have employed a combination of transport assays, luminometry and site-directed mutagenesis. A functional epitope-tagged PepT1 construct (PepT1-FLAG) was co-expressed in Xenopus laevis oocytes with a non-functional but normally trafficked mutant form of the same transporter (W294F-PepT1). The amount of PepT1-FLAG cRNA injected into the oocytes was kept constant, while the amount of W294F-PepT1 cRNA was increased over the mole fraction range of 0 to 1. The uptake of [(3)H]-D: -Phe-L: -Gln into the oocytes was measured at pH(out) 5.5, and the surface expression of PepT1-FLAG was quantified by luminometry. As the mole fraction of injected W294F-PepT1 increased, the uptake of D: -Phe-L: -Gln decreased. This occurred despite the surface expression of PepT1-FLAG remaining constant, and so we can conclude that PepT1 must be a multimer. Assuming that PepT1 acts as a homomultimer, the best fit for the modelling suggests that PepT1 could be a tetramer, with a minimum requirement of two functional subunits in each protein complex. Western blotting also showed the presence of higher-order complexes of PepT1-FLAG in oocyte membranes. It should be noted that we cannot formally exclude the possibility that PepT1 interacts with unidentified Xenopus protein(s). The finding that PepT1 is a multimer has important implications for the molecular modelling of this protein.
Bailey,
How to Make Drugs Orally Active: A Substrate Template for Peptide Transporter PepT1.
2000, Pubmed
Bailey,
How to Make Drugs Orally Active: A Substrate Template for Peptide Transporter PepT1.
2000,
Pubmed
Bolger,
Structure, function, and molecular modeling approaches to the study of the intestinal dipeptide transporter PepT1.
1998,
Pubmed
Casula,
A dominant negative mutant of the KCC1 K-Cl cotransporter: both N- and C-terminal cytoplasmic domains are required for K-Cl cotransport activity.
2001,
Pubmed
,
Xenbase
Covitz,
Membrane topology of the human dipeptide transporter, hPEPT1, determined by epitope insertions.
1998,
Pubmed
Daniel,
The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology.
2004,
Pubmed
Daniel,
Molecular and integrative physiology of intestinal peptide transport.
2004,
Pubmed
Eskandari,
Structural analysis of cloned plasma membrane proteins by freeze-fracture electron microscopy.
1998,
Pubmed
,
Xenbase
Fei,
Expression cloning of a mammalian proton-coupled oligopeptide transporter.
1994,
Pubmed
,
Xenbase
Gebauer,
Three-dimensional quantitative structure-activity relationship analyses of peptide substrates of the mammalian H+/peptide cotransporter PEPT1.
2003,
Pubmed
Goberdhan,
PAT-related amino acid transporters regulate growth via a novel mechanism that does not require bulk transport of amino acids.
2005,
Pubmed
,
Xenbase
Hastrup,
Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment.
2001,
Pubmed
Hastrup,
The human dopamine transporter forms a tetramer in the plasma membrane: cross-linking of a cysteine in the fourth transmembrane segment is sensitive to cocaine analogs.
2003,
Pubmed
Hussain,
Expression and cellular distribution during development of the peptide transporter (PepT1) in the small intestinal epithelium of the rat.
2002,
Pubmed
Konstas,
cAMP-dependent activation of CFTR inhibits the epithelial sodium channel (ENaC) without affecting its surface expression.
2003,
Pubmed
,
Xenbase
Kulkarni,
Transmembrane segment 5 of the dipeptide transporter hPepT1 forms a part of the substrate translocation pathway.
2003,
Pubmed
,
Xenbase
Kulkarni,
Analysis of transmembrane segment 7 of the dipeptide transporter hPepT1 by cysteine-scanning mutagenesis.
2003,
Pubmed
Meredith,
4-aminomethylbenzoic acid is a non-translocated competitive inhibitor of the epithelial peptide transporter PepT1.
1998,
Pubmed
,
Xenbase
Meredith,
Site-directed mutation of arginine 282 to glutamate uncouples the movement of peptides and protons by the rabbit proton-peptide cotransporter PepT1.
2004,
Pubmed
,
Xenbase
Meredith,
Structure and function of eukaryotic peptide transporters.
2000,
Pubmed
Pollok,
Using GFP in FRET-based applications.
1999,
Pubmed
Saito,
Cloning and characterization of a pH-sensing regulatory factor that modulates transport activity of the human H+/peptide cotransporter, PEPT1.
1997,
Pubmed
,
Xenbase
Sitte,
Oligomer formation by Na+-Cl--coupled neurotransmitter transporters.
2003,
Pubmed
Sorkina,
Oligomerization of dopamine transporters visualized in living cells by fluorescence resonance energy transfer microscopy.
2003,
Pubmed
Starremans,
Dimeric architecture of the human bumetanide-sensitive Na-K-Cl Co-transporter.
2003,
Pubmed
,
Xenbase
Temple,
Proton-coupled oligopeptide transport by rat renal cortical brush border membrane vesicles: a functional analysis using ACE inhibitors to determine the isoform of the transporter.
1998,
Pubmed
,
Xenbase
Terada,
Peptide transporters: structure, function, regulation and application for drug delivery.
2004,
Pubmed
